F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: Correlation with magnetic resonance imaging and ultrasound

Clinical Nuclear Medicine

Volumn 34, Issue 8, 2009, Pages 493-495

  Von Falck, Christian ^a   Rodt, Thomas ^a   Joerdens, Steffen ^a   Waldeck, Stephan ^a   Kiesel, Holger ^b   Knapp, Wolfram H ^a   Galanski, Michael ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Departments of Hematology   (Japan)

Author keywords

FDG; MRI; Neurolymphomatosis; NHL; PET; Ultrasound

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER INFILTRATION; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DYSESTHESIA; ECHOGRAPHY; HUMAN; LYMPHOMATOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUADRIPLEGIA;

ADULT; ANIMALS; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, B-CELL; MAGNETIC RESONANCE IMAGING; MALE; MAREK DISEASE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 68949103752     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181abb6ba     Document Type: Article

References (14)

1. Kelly JJ, Karcher DS. Lymphoma and peripheral neuropathy: a clinical review. Muscle Nerve. 2005;31:301-313.
2. Kanter P, Zeidman A, Streifler J, et al. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis. Eur J Hematol. 2005;74:66-69.
3. Baehring JM, Damek D, Martin EC. Neurolymphomatosis. Neuro Oncol. 2003;5:104-115.
4. Strobel K, Fischer K, Hany TF, et al. Sciatic nerve neurolymphomatosis- extent and therapy response assessment with PET/CT. Clin Nucl Mecl. 2007;32:646-648.
5. Shima K, Ishida C, Okino S, et al. A linear lesion along the brachial plexus on FDG-PET in neurolymphomatosis. Intern Med. 2008;47:1159-1160.
6. Dong Q, Wong KK, Avram AM. Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging. Clin Nucl Med. 2008;33:30-31.
7. Rosso SM, de Bruin HG, Wu KL, et al. Diagnosis of neurolymphomatosis with FDG PET. Neurology. 2006;67:722-723.
8. Strobel K, Pestalozzi B, Ciernik I, et al. Changing PET/CT manifestation of neurolymphomatosis. Eur J Nucl Med Mol Imaging. 2006;33:1244.
9. Ozturk E, Arpaci F, Kocaoglu M, et al. Detection of widespread neurolymphomatosis with 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2006;33:975-976.
10. Bokstein F, Goor O, Shihman B, et al. Assessment of neurolymphomatosis by brachial plexus biopsy and PET/CT. Report of a case. J Neurooncol. 2005; 72:163-167.
11. Trojan A, Jermann M, Taverna C, et al. Fusion PET-CT imaging of neurolymphomatosis. Ann Oncol. 2002;13:802-805.
12. Lin M, Kilanowska J, Taper J, et al. Neurolymphomatosis-diagnosis and assessment of treatment response by FDG PET-CT. Hematol Oncol. 2008; 26:43-45.
13. Isasi CR, Lu P, Blaufox MD. A metaanalysis of 18F-2-deoxy-2-fluoro-D- glucose positron emission tomography in the staging and restaging of patients with lymphoma. Cancer. 2005;104:1066-1074.
14. Hutchings M, Specht L. PET/CT in the management of haematological malignancies. Eur J Haematol. 2008;80:369-380.